ASTEPRO 0.15% Insights for Professionals

Coming soon! Sign up for ASTEPRO 0.15% Insights for Professionals, an email series especially for healthcare professionals that delivers valuable information about ASTEPRO 0.15% and the treatment of allergic rhinitis.

*Required fields

  		•


Meda respects your privacy – and is committed to keeping your personal and health information private. In order to send you additional information we will need your name, mailing address and email address.

View our Privacy Policy.

  • Yes, I certify that I am a healthcare professional. I understand that any services and information provided are not medical advice, and are supplied as a courtesy to assist me in forming my own conclusions and making my own decisions about treatment options for my patients with SAR and PAR.
 

Indication

ASTEPRO® (azelastine HCl) Nasal Spray 0.15% is indicated for the relief of the symptoms of seasonal and perennial allergic rhinitis in patients 12 years of age and older.

Important Risk Information

  • Avoid engaging in hazardous occupations requiring complete mental alertness when taking ASTEPRO Nasal Spray 0.15%
  • Avoid concurrent use of alcohol or other central nervous system depressants with ASTEPRO Nasal Spray 0.15%
  • In clinical studies, the most commonly reported adverse reactions, when dosed at 2 sprays per nostril once or twice daily, respectively, included bitter taste (4%, 6%), nasal discomfort (4%, 3%), epistaxis (2%, 1%), and sneezing (1%, 2%)
  • Pregnancy Category C: Based on animal data, may cause fetal harm
    Please see full Prescribing Information
    You are encouraged to report negative side effects of prescription drugs to the FDA.
    Visit www.fda.gov/medwatch, or call 1‐800‐FDA‐1088